Rallybio Corp
SEC CIK 1739410 · RLYB · last insider filing 2026-05-20
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Hunt Ronald | Director | filed 2021 - 2026 |
| Mackay Martin | Director · Executive Chairman | filed 2021 - 2026 |
| Hopfner Robert Lorne | Director | filed 2021 - 2025 |
| Nash Christine A | Director | filed 2022 - 2025 |
| Boudreau Helen M | Director | filed 2021 - 2025 |
| Soteropoulos Paula | Director | filed 2021 - 2025 |
| Liu Hui | Director | filed 2022 - 2025 |
| Chung Wendy | Director | filed 2022 - 2025 |
| Uden Stephen | Director · See Remarks | filed 2021 - 2025 |
| Parmar Kush | Director | filed 2021 - 2024 |
| Shannon Timothy M | Director | filed 2021 - 2022 |
| Iancovici Lucian | Director | filed 2021 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Lieber Jonathan I | See Remarks | filed 2023 - 2026 |
| Ryder Steven | Chief Medical Officer | filed 2021 - 2025 |
| Fryer Jeffrey M | See Remarks | filed 2021 - 2022 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.